Indications
Cryodepleted plasma is used as an alternative to fresh frozen plasma (FFP) for plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).
Modifications
None.
Dosage
Volume depends on local plasma exchange protocols and the patient’s weight with a 10–15 mL/kg dose usually recommended.
Cryodepleted plasma should be ABO compatible with the recipient's red cells. Matching for RhD type is not required.
Updated July 2026
Related resources
Blood Component Information: An Extension of Blood Component Labels
Guide
Information Sheet
